MEMiriam O. Ezenwa

Miriam O. Ezenwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miriam O. Ezenwa has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Diana J. Wilkie

    Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL

    5 shared publications
  • Yingwei Yao

    University of Illinois at Chicago, College of Nursing, Department of Biobehavioral Health Science, 845 S. Damen Avenue, (M/C 802), Chicago, IL 60612, United States; University of Florida, College of Nursing, Department of Biobehavioral Nursing Science, 1225 Center Drive, Room 2203, Gainesville, FL 32610, United States

    3 shared publications
  • Marie L. Suarez

    Department of Biobehavioral Health Science, University of Illinois at Chicago, College of Nursing, Illinois, USA

    2 shared publications
  • Marie L. Suarez

    University of Illinois Chicago, College of Nursing, Department of Human Development Nursing Science, USA

    2 shared publications
  • Robert E. Molokie

    Department of Biopharmaceutical Sciences, College of Pharmacy, Cancer Center, University of Illinois at Chicago, Chicago, IL, USA

    2 shared publications
  • Zaijie Jim Wang

    Department of Biopharmaceutical Sciences, College of Pharmacy, Cancer Center, University of Illinois at Chicago, Chicago, IL, USA

    2 shared publications

Latest Publications

  • Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit

    by Robert E. Molokie, Chariz Montminy, Corissa Dionisio, Muhammad Ahmen Farooqui, Michel Gowhari, Yingwei Yao, Marie L. Suarez, Miriam O. Ezenwa, Judith M. Schlaeger, Zaijie J. Wang, et al.


  • Patient reported outcomes using Internet-based tablets to inform hospice care for minority and nonminority patients with cancer.

    by Timothy McCurry, Yingwie Yao, Miriam O Ezenwa, Anayza Gill, Theresa Hipp, Robert Shea, Jacob Miller, Jesus Carrasco, David Shuey, Karen Frank, et al.

    10115 Background: Unrelieved symptoms for cancer patients receiving hospice care could be influenced by lack of systematically collected PRO. Many hospice nurses now use tablets for care process documentation, but tablets are not commonly used to collect PRO. The study aim was to compare pain and symptom distress among minority and NHW hospice patients with cancer who reported their symptoms via an Internet enabled tablet with data transmitted electronically to their hospice nurses. Methods: From two hospices, we screened 2,814 cancer patients, 819 were eligible, 211 consented, and 209 completed baseline measures. In their homes, patients (mean age 68±15; 49% male; 33% African American, 46% NHW, 18% Hispanic, 3% other/unknown) used an Internet-enabled Samsung tablet to complete the valid, reliable PAINReportIt (pain intensity now, least and worst in the past 24 hours [0-10]) and Symptom Distress Scale (SDS, 0-5). Data were written to a secure server, extracted from the database, and analyzed using statistical software R. Results: Ease of tablet use was high; missing data were minimal (2.8%). Mean pain intensity scores for now, least, and worst pain in the past 24 hours were 4.7±2.7, 3.1±2.3, 7.1±2.3, respectively. The average of these pain intensity scores (API) was 5±2 and the average SDS was 2.6±.6. Patient age was negatively correlated with both API (r= -.26, p< .001) and SDS (r= -.20, p= .004). Neither API nor SDS scores differed by the patient’s gender or ethnicity. Compared to NHW, minority patients reported higher API (diff= .73, p= .01), but did not differ significantly in their reported SDS scores (diff= -.04, p= .61). Further examination of API scores showed that, controlling for hospice difference and age, Hispanics reported significantly higher API than NHW (diff= 1.00, p= .01) but the gap between African Americans and NHW was not significant (diff= .61, p= .10). Conclusions: Improvements are needed to promote comfort at the end of life, especially for Hispanics. Tablet-based PRO offers a novel way for hospice cancer patients to add their unfiltered viewpoint to their hospice record. The influence of the PROs on analgesic prescriptions and 1-week pain outcomes are under study. Clinical trial information: NCT02026115.

  • A randomized controlled pilot study feasibility of a tablet‐based guided audio‐visual relaxation intervention for reducing stress and pain in adults with sickle cell disease

    by Miriam O. Ezenwa, Yingwei Yao, Christopher G. Engeland, Robert E. Molokie, Zaijie Jim Wang, Marie L. Suarez, Diana J. Wilkie

    Aim: To test feasibility of a guided audio‐visual relaxation intervention protocol for reducing stress and pain in adults with sickle cell disease.Background: Sickle cell pain is inadequately controlled using opioids, necessitating further intervention such as guided relaxation to reduce stress and pain.Design: Attention‐control, randomized clinical feasibility pilot study with repeated measures.Methods: Randomized to guided relaxation or control groups, all patients recruited between 2013–2014 during clinical visits, completed stress and pain measures via a Galaxy Internet‐enabled Android tablet at the Baseline visit (pre/post intervention), 2‐week posttest visit and also daily at home between the two visits. Experimental group patients were asked to use a guided relaxation intervention at the Baseline visit and at least once daily for 2 weeks. Control group patients engaged in a recorded sickle cell discussion at the Baseline visit. Data were analysed using linear regression with bootstrapping.Results: At baseline, 27/28 of consented patients completed the study protocol. Group comparison showed that guided relaxation significantly reduced current stress and pain. At the 2‐week posttest, 24/27 of patients completed the study, all of whom reported liking the study. Patients completed tablet‐based measures on 71% of study days (69% in control group, 72% in experiment group). At the 2‐week posttest, the experimental group had significantly lower composite pain index scores, but the two groups did not differ significantly on stress intensity.Conclusion: This study protocol appears feasible. The tablet‐based guided relaxation intervention shows promise for reducing sickle cell pain and warrants a larger efficacy trial.Trial registration: The ClinicalTrials.gov Identifier is: NCT02501447.


  • Perceived Injustice Predicts Stress and Pain in Adults with Sickle Cell Disease

    by Miriam O. Ezenwa, Robert E. Molokie, Diana J. Wilkie, Marie L. Suarez, Yingwei Yao


  • Satisfied or not satisfied: pain experiences of patients with sickle cell disease

    by Miriam O. Ezenwa, Robert E. Molokie, Zaijie Jim Wang, Marie L. Suarez, Yingwei Yao, Diana J. Wilkie

    Aims: To examine the relationship between pain and satisfaction in patients with sickle cell disease.Background: Frequency and severity of unrelieved sickle cell pain are positively associated with mortality. Yet, information is scarce on whether sickle cell patients are satisfied with their pain level.Design: A cross‐sectional, correlational analysis of baseline data from a randomized clinical trial.Methods: A randomized sample of adult outpatients was recruited between February 2007–March 2011. Patients completed the PAINReportIt®, containing measures of pain, satisfaction and socio‐demographics. We analysed data using Kendall's rank correlations, analysis of variance, Tukey–Kramer post hoc tests, Fisher's tests and proportional odds logistic regression.Results: There were statistically significant correlations between pain outcomes and satisfaction with pain level, but average pain intensity more strongly discriminated groups based on satisfaction with pain level. Among pain variables bivariately associated with patient satisfaction with pain level, only pain expectation maintained its significant relationship with satisfaction with pain level when average pain intensity was controlled. A smaller percentage of our sickle cell patients reported moderate to severe pain intensity (28%) or high composite pain index (39%), while reporting being satisfied with pain their level than reported in earlier studies using different measures and populations (70‐94%).Conclusion: Satisfaction with pain level was an unambiguous measure of patient satisfaction and a promising indicator of pain that did not show the paradoxical relationship between satisfaction and pain seen with past measures.


    • 1 January 2012
      • Vol. 5  (3) , 12-26

    Racial Disparities in Pain Management in Primary Care

    by Miriam O. Ezenwa, Michael F. Fleming

    This descriptive, cross-sectional, secondary data analysis was conducted to examine racial disparities in pain management of primary care patients with chronic nonmalignant pain using chronic opioid therapy. Data from 891 patients, including 201 African Americans and 691 Caucasians were used to test an explanatory model for these disparities. We predicted that: (1) African American patients would report worse pain management and poor quality of life (QOL) than Caucasians; (2) the association between race and pain management would be mediated by perceived discrimination relating to hopelessness; and (3) poor pain management would negatively affect QOL. Results revealed significant differences between African Americans and Caucasians on pain management and QOL, with African Americans faring worse. The proposed mediational model, which included race, perceived discrimination, hopelessness, and pain management was supported: (1) African Americans compared to Caucasians had higher perceived discrimination, (2) perceived discrimination was positively associated with hopelessness, and (3) higher hopelessness was associated with worse pain management. Further, pain management predicted QOL. This is the first study in which an explanatory model for the racial disparities in pain management of primary care patients with chronic nonmalignant pain was examined. Perceived discrimination and hopelessness were implicated as explanatory factors for the disparities.